China Health EV/EBITDA
What is the EV/EBITDA of China Health?
The EV/EBITDA of China Health Group Inc. is 7.21
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on HKSE compared to China Health
What does China Health do?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Companies with ev/ebitda similar to China Health
- Bowl America has EV/EBITDA of 7.20
- Zhejiang Chang'an Renheng Technology Co has EV/EBITDA of 7.20
- Intense Technologies has EV/EBITDA of 7.20
- Zenitel NV has EV/EBITDA of 7.20
- Next Solar Fund has EV/EBITDA of 7.20
- DS Smith Plc has EV/EBITDA of 7.21
- China Health has EV/EBITDA of 7.21
- Bodal Chemicals has EV/EBITDA of 7.21
- V2X Inc has EV/EBITDA of 7.21
- Hertz Global has EV/EBITDA of 7.21
- Information Services has EV/EBITDA of 7.21
- Pathward Inc has EV/EBITDA of 7.21
- Impellam PLC has EV/EBITDA of 7.22